TRAF3 interacting protein 2 (TRAF3IP2; ACT1); inducible nitric oxide synthase 2 (NOS2; iNOS); F-box and leucine-rich repeat protein 19 (FBXL19); nuclear factor of κ light polypeptide gene enhancer in B cells inhibitor α (NKFBIA); proteasome subunit α-type 6 (PSMA6); endoplasmic reticulum aminopeptidase 1 (ERAP1); pituitary tumor-transforming gene 1 (PTTG1); CUB and sushi multiple domains 1 (CSMD1); gap junction protein β2, 26kDa (GJB2); serpin peptidase inhibitor clade B member 8 (SERPINB8); zinc finger protein 816A (ZNF816A) BriefCommunication Pages: 1437 - 1437
Bruton's tyrosine kinase (BTK); tumor necrosis factor-α (TNF-α) BriefCommunication Pages: 1438 - 1438
β-site APP-cleaving enzyme 1 (BACE1); amyloid-β (A4) precursor protein (APP) BriefCommunication Pages: 1449 - 1449
Microtubule-associated protein-τ (MAPT; tau; FTDP-17); presenilin 1 (PSEN1; PS1) BriefCommunication Pages: 1451 - 1451
High throughput DNA sequencing to diagnose hereditary hearing loss BriefCommunication Pages: 1457 - 1457
Induced pluripotent stem (iPS) cells for production of human platelets BriefCommunication Pages: 1458 - 1458
Behavioral screen in Drosophila for potential analgesic targets BriefCommunication Pages: 1459 - 1459
Method for converting vascular endothelial cells into multipotent stem cell–like cells BriefCommunication Pages: 1461 - 1461
Strategy to produce safer glucocorticoid drugs by avoiding activation of liver X receptor-β (NR1H2; LXR-β) BriefCommunication Pages: 1462 - 1462
MRI of magnetic nanoparticles to detect islet inflammation and monitor diabetes progression BriefCommunication Pages: 1463 - 1463